Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 079069
Company: MYLAN
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
STAVUDINE STAVUDINE 15MG CAPSULE;ORAL Prescription AB No No
STAVUDINE STAVUDINE 20MG CAPSULE;ORAL Prescription AB No No
STAVUDINE STAVUDINE 30MG CAPSULE;ORAL Prescription AB No No
STAVUDINE STAVUDINE 40MG CAPSULE;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
12/29/2008 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
03/09/2012 SUPPL-3 Labeling-Package Insert, Labeling-Medication Guide

Label is not available on this site.

08/01/2011 SUPPL-2 Labeling-Container/Carton Labels, Labeling-Medication Guide, REMS-Proposal, Labeling-Package Insert

Label is not available on this site.

04/07/2011 SUPPL-1 Labeling-Package Insert, Labeling-Container/Carton Labels

Label is not available on this site.

STAVUDINE

CAPSULE;ORAL; 15MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
STAVUDINE STAVUDINE 15MG CAPSULE;ORAL Prescription No AB 077672 AUROBINDO PHARMA
STAVUDINE STAVUDINE 15MG CAPSULE;ORAL Prescription No AB 078957 HETERO LABS LTD III
STAVUDINE STAVUDINE 15MG CAPSULE;ORAL Prescription No AB 079069 MYLAN
ZERIT STAVUDINE 15MG CAPSULE;ORAL Prescription Yes AB 020412 BRISTOL MYERS SQUIBB

CAPSULE;ORAL; 20MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
STAVUDINE STAVUDINE 20MG CAPSULE;ORAL Prescription No AB 077672 AUROBINDO PHARMA
STAVUDINE STAVUDINE 20MG CAPSULE;ORAL Prescription No AB 078957 HETERO LABS LTD III
STAVUDINE STAVUDINE 20MG CAPSULE;ORAL Prescription No AB 079069 MYLAN
ZERIT STAVUDINE 20MG CAPSULE;ORAL Prescription Yes AB 020412 BRISTOL MYERS SQUIBB

CAPSULE;ORAL; 30MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
STAVUDINE STAVUDINE 30MG CAPSULE;ORAL Prescription No AB 077672 AUROBINDO PHARMA
STAVUDINE STAVUDINE 30MG CAPSULE;ORAL Prescription No AB 078957 HETERO LABS LTD III
STAVUDINE STAVUDINE 30MG CAPSULE;ORAL Prescription No AB 079069 MYLAN
ZERIT STAVUDINE 30MG CAPSULE;ORAL Prescription Yes AB 020412 BRISTOL MYERS SQUIBB

CAPSULE;ORAL; 40MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
STAVUDINE STAVUDINE 40MG CAPSULE;ORAL Prescription No AB 077672 AUROBINDO PHARMA
STAVUDINE STAVUDINE 40MG CAPSULE;ORAL Prescription No AB 078957 HETERO LABS LTD III
STAVUDINE STAVUDINE 40MG CAPSULE;ORAL Prescription No AB 079069 MYLAN
ZERIT STAVUDINE 40MG CAPSULE;ORAL Prescription Yes AB 020412 BRISTOL MYERS SQUIBB

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English